RESEARCHERS around the world can look forward to accessing technology which will help them to understand how diseases progress in their early stages thanks to a deal between life sciences giant Merck and the University of Edinburgh’s commercialisation arm, Edinburgh Research & Innovation.
The licence agreement is based on research hailed as a major breakthrough in peptide chemistry and biomedical sciences, paving the way for a better understanding of disease onset and behaviour.
The technology is based on using natural peptide mimics as “disease reporters” by applying a fluorescent compound or re-agent that makes them easier to identify.
Academics at Edinburgh’s School of Clinical Sciences, led by Dr Marc Vendrell, carried out the research alongside partners at The University of Barcelona and The University of Manchester.
Dr Vendrell said the fluorescent re-agent is so powerful it can allow scientists tell very small differences between healthy and diseased cells, which in turn can have a big impact on diagnosis and treating diseases.
Dr Vendrell said: “We have developed a technology that allows us to prepare fluorescent re-agents without affecting the normal behaviour of these re-agents. That opens a whole range of opportunities for people who are studying disease… to detect little differences that can help develop better diagnostics, or better therapies.”
The initial stage of the research was funded by the EU Commission in the form of a Marie Curie career integration grant.
Asked whether he was concerned medical research in Scottish universities is under threat because of the Brexit vote, Dr Vendrell said that “closing any doors not only to funding but to collaborations… within the EU is not a good thing.”
He noted: “It is not a good outcome for anybody who is interested in science and research in general.”
Why are you making commenting on The Herald only available to subscribers?
It should have been a safe space for informed debate, somewhere for readers to discuss issues around the biggest stories of the day, but all too often the below the line comments on most websites have become bogged down by off-topic discussions and abuse.
heraldscotland.com is tackling this problem by allowing only subscribers to comment.
We are doing this to improve the experience for our loyal readers and we believe it will reduce the ability of trolls and troublemakers, who occasionally find their way onto our site, to abuse our journalists and readers. We also hope it will help the comments section fulfil its promise as a part of Scotland's conversation with itself.
We are lucky at The Herald. We are read by an informed, educated readership who can add their knowledge and insights to our stories.
That is invaluable.
We are making the subscriber-only change to support our valued readers, who tell us they don't want the site cluttered up with irrelevant comments, untruths and abuse.
In the past, the journalist’s job was to collect and distribute information to the audience. Technology means that readers can shape a discussion. We look forward to hearing from you on heraldscotland.com
Comments & Moderation
Readers’ comments: You are personally liable for the content of any comments you upload to this website, so please act responsibly. We do not pre-moderate or monitor readers’ comments appearing on our websites, but we do post-moderate in response to complaints we receive or otherwise when a potential problem comes to our attention. You can make a complaint by using the ‘report this post’ link . We may then apply our discretion under the user terms to amend or delete comments.
Post moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours.
Read the rules here